Back to search

Article

Impact of BRAF V600E Mutation on Surgical Management and Outcomes in Low-Risk Differentiated Thyroid Carcinoma (T1–2N0M0)

2026-05-18

Abstract excerpt

<title>Abstract</title> <p>Background The clinical relevance of the BRAF V600E mutation in the surgical management of early-stage differentiated thyroid carcinoma (DTC) remains unclear. Although common in papillary thyroid carcinoma, its role in guiding surgical decisions in low-risk disease is still debated. Methods We conducted a retrospective single-center study of patients with low-risk DTC (T1–2N0M0) treat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
79236d3e-b392-5b7b-9b16-459edf5c560e
DOI
10.21203/rs.3.rs-9407674/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of BRAF V600E Mutation on Surgical Management and Outcomes in Low-Risk Differentiated Thyroid Carcinoma (T1–2N0M0)DOI 10.21203/rs.3.rs-9407674/v1
Select a neighboring publication to make it the new centre.